Helen Tayton-Martin

Company: Adaptimmune
Job title: CBO
Seminars:
The Road to Commercialization: Preparing for BLA, Commercial Readiness, Upscaling Manufacturing for the First Commercial TCR-T Cell Therapy 9:30 am
• Regulatory challenges for an autologous TCR-T cell therapy and companion diagnostics • Creating a commercial infrastructure to enter a field where prescribers and payers have limited cell therapy experience in solid tumors • Manufacturing challenges for a product ready for a franchiseRead more
day: Day One